Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sanofi (SNY) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Sanofi (SNY) over the last 17 years, with Q4 2025 value amounting to $15.2 billion.

  • Sanofi's Cost of Revenue rose 765.5% to $15.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $32.5 billion, marking a year-over-year increase of 3210.84%. This contributed to the annual value of $14.7 billion for FY2025, which is 317.95% up from last year.
  • Latest data reveals that Sanofi reported Cost of Revenue of $15.2 billion as of Q4 2025, which was up 765.5% from $10.9 billion recorded in Q3 2025.
  • Over the past 5 years, Sanofi's Cost of Revenue peaked at $15.2 billion during Q4 2025, and registered a low of $3.0 billion during Q1 2025.
  • For the 5-year period, Sanofi's Cost of Revenue averaged around $6.5 billion, with its median value being $3.7 billion (2021).
  • In the last 5 years, Sanofi's Cost of Revenue soared by 127669.53% in 2021 and then crashed by 930.62% in 2024.
  • Quarter analysis of 5 years shows Sanofi's Cost of Revenue stood at $14.0 billion in 2021, then fell by 0.34% to $14.0 billion in 2022, then dropped by 2.76% to $13.6 billion in 2023, then rose by 3.86% to $14.1 billion in 2024, then grew by 7.66% to $15.2 billion in 2025.
  • Its Cost of Revenue stands at $15.2 billion for Q4 2025, versus $10.9 billion for Q3 2025 and $3.4 billion for Q2 2025.